-
COVID-19 Treatment a Logistical Nightmare
The President touted monoclonal antibodies as a "miracle cure" for COVID-19. In Wired, CP3 Director Walid Gellad explains the complications of distribution and administration.
Read the article -
Medicare Beneficiaries See Pharmacists More Than PCPs
In a new JAMA Network Open paper, CP3 Associate Director Dr. Inma Hernandez & team show that Medicare beneficiaries encounter community pharmacists more often than PCPs. Pharmacists are uniquely positioned to be patient partners in prevention and disease management efforts.
Read the paper here -
COVID-19 Vaccine Seminar
On 10/20, we hosted expert panel from Pitt & CMU on 10/20 to learn about COVID-19 vaccine approval, hesitancy, allocation, & risk communication.
Watch the recording here -
Dentists Prescribe Excessive Opioids
Dr. Katie Suda is lead author of a pivotal study examining patterns of excessive opioid prescribing among dentists.
Read more about the study
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
